Asaf Wyszynski

Chief Scientific Officer and Co-Founder, Genextropy, Hanover, New Hampshire


  • PhD, '14, Program in Experimental and Molecular Medicine, Dartmouth College
  • BS, '08, Rutgers University

Selected Publications

  • Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int. 2014.

  • Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Celaya MO, Zens MS, Karagas MR, Andrew AS. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer. 2014; 120(3):408-14.